Active Filters

  • (-) PSI Authors = Hasler, Roger
  • (-) Full Text ≠ Restricted
Search Results 1 - 3 of 3
  • RSS Feed
Select Page
Developments toward the implementation of <sup>44</sup>Sc production at a medical cyclotron
van der Meulen, N. P., Hasler, R., Talip, Z., Grundler, P. V., Favaretto, C., Umbricht, C. A., … Braccini, S. (2020). Developments toward the implementation of 44Sc production at a medical cyclotron. Molecules, 25(20), 4706 (16 pp.). https://doi.org/10.3390/molecules25204706
The use of PSI's IP2 beam line towards exotic radionuclide development and its application towards proof-of-preclnical and clinical studies
van der Meulen, N. P., Eichler, R., Grundler, P. V., Hasler, R., Hirzel, W., Joray, S., … Braccini, S. (2020). The use of PSI's IP2 beam line towards exotic radionuclide development and its application towards proof-of-preclnical and clinical studies. In L. Conradie, J. Garrett De Villiers, & V. R. W. Schaa (Eds.), International conference on cyclotrons and their applications: Vol. 22. CYC2019. 22nd international conference on cyclotrons and their applications (pp. 132-135). https://doi.org/10.18429/JACoW-Cyclotrons2019-TUA03
Therapeutic potential of <sup>47</sup>Sc in comparison to <sup>177</sup>Lu and <sup>90</sup>Y: preclinical investigations
Siwowska, K., Guzik, P., Domnanich, K. A., Monné Rodríguez, J. M., Bernhardt, P., Ponsard, B., … Müller, C. (2019). Therapeutic potential of 47Sc in comparison to 177Lu and 90Y: preclinical investigations. Pharmaceutics, 11(8), 424 (13 pp.). https://doi.org/10.3390/pharmaceutics11080424